```html

Ymer's Disease (Obsolete Term for Brucellosis)

Overview

Ymer’s disease is an historical name that was once used for what modern medicine calls brucellosis. Brucellosis is a bacterial infection caused by organisms of the genus Brucella. The disease is zoonotic – it is transmitted from animals to humans – and is most common in regions where livestock are raised with limited veterinary control.

Who it affects: People who work closely with animals (farmers, veterinarians, abattoir workers, shepherds), hunters, laboratory staff, and travelers to endemic areas are at the highest risk. In many low‑ and middle‑income countries, the infection is also seen in the general population through consumption of unpasteurized dairy products.

Prevalence: According to the World Health Organization (WHO), there are an estimated 500,000 new human cases of brucellosis each year, with the highest incidence in the Mediterranean basin, Middle East, Central Asia, Sub‑Saharan Africa, and parts of Latin America. In the United States, the Centers for Disease Control and Prevention (CDC) reports < 1,000 cases annually, reflecting the disease’s rarity in high‑income regions where animal vaccination programs are well established.

Symptoms

Brucellosis has a notoriously variable clinical picture. The incubation period ranges from 5 days to 2 months. Symptoms may fluctuate, relapse, or become chronic. Below is a comprehensive list with brief descriptions:

• Fever – Often low‑grade (38–40 °C) and intermittent (“undulant fever”).
• Night sweats – Profuse sweating, especially during sleep.
• Fatigue & weakness – Persistent tiredness lasting weeks to months.
• Musculoskeletal pain – Arthralgia, myalgia, low‑back pain; may progress to true arthritis, especially of the sacroiliac joints.
• Headache – Typically dull, can be severe in the acute phase.
• Loss of appetite & weight loss – Often >5 % of body weight in prolonged disease.
• Gastrointestinal upset – Nausea, abdominal pain, occasional diarrhea.
• Hepatomegaly & splenomegaly – Enlarged liver or spleen detected on physical exam.
• Hepatitis – Mild elevation of liver enzymes (ALT, AST) in up to 30 % of patients.
• Genitourinary involvement – Epididymo‑orchitis in men, which can mimic testicular torsion.
• Neurologic manifestations – “Neurobrucellosis” presenting as meningitis, encephalitis, or peripheral neuropathy; occurs in < 5 % of cases.
• Cardiac involvement – Endocarditis is rare (<1 %) but carries a high mortality.
• Ocular disease – Uveitis or retinal vasculitis, especially in chronic infection.
• Pregnancy complications – Spontaneous abortion or stillbirth in infected pregnant women.

Because symptoms overlap with many other febrile illnesses (e.g., malaria, typhoid, viral hepatitis), a high index of suspicion is essential for timely diagnosis.

Causes and Risk Factors

Microbial cause

Brucellosis is caused by Gram‑negative, intracellular coccobacilli. The most common species affecting humans are:

• Brucella melitensis – from goats and sheep (most virulent).
• Brucella abortus – from cattle.
• Brucella suis – from swine.
• Brucella canis – from dogs (primarily causing canine brucellosis, but zoonotic potential exists).

Transmission routes

• Ingestion of unpasteurized milk, cheese, yogurt, or other dairy products from infected animals.
• Direct contact with contaminated animal tissues, placentas, or aborted fetuses – skin cuts or mucous membranes provide entry points.
• Inhalation of aerosolized bacteria in laboratory or slaughter‑house settings.
• Rare vertical transmission from mother to fetus.

Risk factors

• Occupational exposure – livestock farming, veterinary practice, wildlife handling, meat processing.
• Living in or traveling to endemic rural areas.
• Consumption of unpasteurized dairy products.
• Being male – epidemiologic data show a 2–3 : 1 male‑to‑female ratio, reflecting occupational patterns.
• Immunosuppression – HIV infection, chronic steroid use, or other conditions that impair cell‑mediated immunity increase susceptibility and may lead to more severe disease.

Diagnosis

Because clinical features are nonspecific, laboratory confirmation is essential.

Serologic tests

• Standard Agglutination Test (SAT) – Detects IgM/IgG antibodies; a titer ≥1:160 in endemic areas is considered diagnostic.
• Enzyme‑Linked Immunosorbent Assay (ELISA) – Provides separate IgM and IgG titres; useful for differentiating acute from chronic infection.
• Coombs anti‑Brucella test – Improves sensitivity when SAT is negative but clinical suspicion remains high.

Culture

Blood, bone‑marrow, or cerebrospinal fluid (CSF) cultures remain the gold standard but are slow (up to 6 weeks) and require biosafety level 3 (BSL‑3) facilities. Positive cultures confirm diagnosis and allow species identification, which guides therapy.

Molecular methods

• Polymerase Chain Reaction (PCR) – Detects bacterial DNA in blood or tissue; rapid (hours) and highly specific, increasingly available in reference labs.
• Real‑time PCR – Quantifies bacterial load, helpful for monitoring response to therapy.

Imaging (when indicated)

• Chest X‑ray or CT – May reveal pulmonary infiltrates or mediastinal lymphadenopathy.
• Abdominal ultrasound – Detects hepatosplenomegaly or focal lesions.
• MRI of the spine or brain – Used for suspected neurobrucellosis or spinal involvement.

Diagnostic algorithm (summary)

1. Clinical suspicion based on exposure history + compatible symptoms.
2. Order serology (SAT/ELISA) and blood cultures simultaneously.
3. If serology positive & cultures pending → start empiric therapy.
4. For focal disease (e.g., arthritis, endocarditis, neuro‑) obtain targeted imaging and, when safe, tissue culture or PCR.

Treatment Options

Effective therapy requires combination regimens to prevent relapse, which occurs in up to 10–20 % of inadequately treated cases.

First‑line antibiotic regimens (per CDC, WHO, and Mayo Clinic)

• Doxycycline 100 mg PO twice daily + Rifampin 600–900 mg PO once daily for 6 weeks (for uncomplicated disease).
• Doxycycline 100 mg PO twice daily + Streptomycin 1 g IM daily for 2–3 weeks (alternative for patients unable to tolerate rifampin).
• Doxycycline 100 mg PO twice daily + Gentamicin 5 mg/kg IV/IM daily for 7–10 days (used for severe or focal disease such as neurobrucellosis).

Special considerations

• Pregnancy – Use trimethoprim‑sulfamethoxazole (if no sulfa allergy) or rifampin monotherapy; avoid doxycycline and streptomycin due to fetal toxicity.
• Pediatric patients – Favor rifampin + trimethoprim‑sulfamethoxazole for 6 weeks; avoid doxycycline in children <8 years.
• Renal impairment – Dose‑adjust streptomycin/gentamicin; monitor trough levels.

Adjunctive measures

• Analgesics and antipyretics for symptom relief.
• Physical therapy for persistent arthralgia or back pain.
• Supportive care for complications (e.g., surgical drainage of abscesses, valve replacement for endocarditis).

Monitoring and follow‑up

Repeat serology at 4–6 weeks and at the end of therapy to ensure a four‑fold decline in IgG titres. Persistent high titres may indicate relapse and warrant re‑evaluation.

Living with Ymer's disease (obsolete term for brucellosis)

Even after successful treatment, some patients experience chronic fatigue, joint pain, or neuro‑cognitive symptoms. The following strategies help maintain quality of life:

• Gradual return to activity – Begin with low‑impact exercises (walking, swimming) and increase intensity as tolerated.
• Joint care – Use heat/ice, over‑the‑counter NSAIDs, and consider a referral to a rheumatologist if arthritis persists beyond 3 months.
• Nutrition – A balanced diet rich in protein, vitamins C and D, and iron supports immune recovery.
• Hydration – Adequate fluid intake helps resolve fever‑related dehydration.
• Stress management – Mind‑body techniques (deep breathing, meditation) can alleviate fatigue and improve sleep.
• Vaccination review – Ensure up‑to‑date tetanus, influenza, and COVID‑19 vaccines; avoid live vaccines if immunosuppressed.
• Follow‑up appointments – Keep regular visits with your primary care provider or infectious‑disease specialist for at least 12 months post‑treatment.

Prevention

Because brucellosis is preventable, public‑health measures focus on animal control and food safety.

For individuals

• Consume only pasteurized milk and dairy products. If you must use raw milk, boil it for at least 1 minute.
• Wear protective gloves, goggles, and masks when handling animal births, abortions, or carcasses.
• Wash hands thoroughly after contact with animals or animal products.
• Use proper meat‑cooking techniques – bring internal temperatures to ≥71 °C (160 °F) for pork, ≥63 °C (145 °F) for lamb, and ≥74 °C (165 °F) for poultry.
• Travelers to endemic regions should avoid raw dairy and seek pre‑travel counseling.

For communities & public health authorities

• Vaccinate livestock (e.g., B. melitensis Rev‑1 vaccine for sheep/goats, B. abortus S19 or RB51 for cattle).
• Implement test‑and‑slaughter or culling programs for infected herds.
• Enforce strict pasteurization regulations for commercial dairy.
• Provide occupational health training and personal‑protective equipment for high‑risk workers.
• Maintain surveillance systems to detect outbreaks early (CDC’s National Notifiable Diseases Surveillance System and WHO’s International Health Regulations).

Complications

If left untreated or inadequately treated, brucellosis can affect virtually any organ system:

• Chronically relapsing fever – Persistent low‑grade fever for months to years.
• Osteo‑articular disease – Spondylitis, sacroiliitis, or chronic septic arthritis, potentially leading to permanent joint damage.
• Neurobrucellosis – Meningitis, encephalitis, radiculoneuritis, or peripheral neuropathy; may cause lasting neurological deficits.
• Endocarditis – The most lethal complication; valve destruction often necessitates surgical replacement.
• Genitourinary involvement – Epididymo‑orchitis, prostatitis, or chronic urinary tract infection.
• Hepatobiliary disease – Chronic hepatitis, liver abscesses, or cholestasis.
• Pregnancy loss – Spontaneous abortion, preterm delivery, or intra‑uterine fetal death.
• Septic shock – Rare but possible in overwhelming infection, especially in immunocompromised hosts.

When to Seek Emergency Care

---

**Sources**: Mayo Clinic, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), National Institutes of Health (NIH) – National Library of Medicine, Cleveland Clinic, International Journal of Infectious Diseases (2022), Clinical Infectious Diseases (2021).

```